2024-12-06 Hesai Technology HaiPress
SHANGHAI,Dec. 5,2024 -- Hesai (NASDAQ: HSAI),the global leader in lidar solutions,announced this week that it will be the exclusive provider of automotive long-range lidar for Changan Automobile's new intelligent driving platform. The order volume for Hesai's ATX compact lidar model,released in April of this year,is expected to exceed 1.5 million units over the next few years.
According to the agreement,Hesai will provide lidar products for more than 10 vehicle models from multiple Changan Automobile brands,with the platform's first model expected to enter mass production in the second half of 2025. In line with the initial strategic partnership established in 2022,the Changan Nevo E07,equipped with two Hesai AT128 lidars,was successfully launched in October of this year and received widespread praise from the market.
The ATX model is a compact ultra-high-resolution long-range lidar featuring Hesai's proprietary platform technology,which enhances point cloud resolution while decreasing the unit's volume,weight,and power consumption. Hesai's ATX is steadily approaching mass production with multiple automotive companies selecting the ATX as a standard configuration for mass-production models in 2025.
In the near future,Hesai's ATX model will empower multiple brands and vehicle models to enhance road safety with Changan Automobile's intelligent driving platform. Hesai will continue to work closely with Changan Automobile to bring the benefits of advanced intelligent driving functions to more people worldwide.
Cangxi County Holds 2026 New Year's Cultural Performance for the Public
The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange
Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement
©copyright 2009-2020 Diet Tips Daily